Core Insights - The report highlights the performance of the Beijing Stock Exchange (BSE) on February 12, 2026, with the BSE 50 index closing at 1,533.17 points, reflecting a change of 0.50% [3] - The overall trading volume on the BSE was 19.263 billion yuan, with a total of 721 million shares traded, indicating a decrease compared to the previous week's average daily trading volume of 20.484 billion yuan [3] - The report notes that the BSE's overall valuation stands at a price-to-earnings (P/E) ratio of 47.22 times, which is higher than the P/E ratios of the ChiNext and STAR Market, at 46.32 times and 78.83 times respectively [3][10] Market Performance - On February 12, 2026, the BSE saw mixed performance across various sectors, with the pharmaceutical and biotechnology sector leading with a gain of 6.2%, while the oil and petrochemical sector experienced a decline of 6.8% [3] - Among the 294 listed companies on the BSE, 113 companies saw their stock prices rise, while 171 companies experienced declines, with Haisheng Medical leading the gains at 172.86% [3][7] Valuation Analysis - The average P/E ratio for the BSE-listed companies is reported at 47.22 times, with the highest sector valuation in non-ferrous metals at 123.5 times, followed by telecommunications at 93.5 times [3][10] - The report indicates a continuous trend of higher valuations for BSE companies compared to those listed on the ChiNext [10] Trading Activity - The trading activity on the BSE was characterized by a turnover rate of 2.80%, with notable trading volumes in companies such as Binhang Technology, which had a transaction volume of 1.549 billion yuan [3][6] - The report provides detailed data on the top gainers and losers, with Haisheng Medical and ST Yunchuang being highlighted for their significant price movements [7][8]
银河证券北交所日报-20260212